Lexus Exec: Autonomous Vehicles Are Still Five Years Away
The driverless car revolution is still a long way down the road.
That’s according to Jeff Bracken, Group Vice President at Lexus, who told Cheddar that autonomous vehicles won’t take over the industry for another “five or 10 years.”
But when we get there, he said, there “will be huge safety benefits.”
His comments come in light of Uber’s fatal driverless car crash last week, which has left the industry reeling. Late Wednesday, a top exec at the company’s autonomous unit reportedly stepped down.
Meanwhile Lexus unveiled its new UX model at the New York International Auto Show earlier in the day. It will be the company’s first car fitted with Amazon’s Alexa system. Other features include a “predictive efficient driver.”
“This vehicle, from a technology standpoint, will get to know you,” explained Bracken.
“So if the vehicle recognizes it’s on a similar route and you’re going up a hill [for example], it will actually move into the electric motor mode so that it saves the gas.”
The carmaker hopes this model will attract millennials and is even considering offering a subscription-style financing model to do that.
Though still in planning phases, Bracken revealed that the subscription could include things like “maintenance on the vehicle.”
The new UX model is scheduled to hit dealerships in December.
For the full interview, [click here](https://cheddar.com/videos/lexus-unveils-a-new-compact-crossover-for-the-urban-explorer).
Smoke that filled the cabin of a Delta flight as it took off from the Atlanta airport in February was so thick the led flight attendant had trouble seeing past the first row of passengers and the pilots donned oxygen masks as a precaution.
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
